STOCK TITAN
  1. Home
  2. Sec-filings
  3. MEDP
  4. [Form 4] Medpace Holdings, Inc. Insider Trading Activity

Medpace (NASDAQ: MEDP) GC exercises options and receives major equity grants

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Medpace Holdings, Inc. General Counsel & Corporate Secretary Stephen P. Ewald exercised employee stock options to acquire 3,500 shares of common stock at $138.87 per share. After this exercise, he directly holds 20,343 shares of common stock.

He also received equity compensation awards on the same date: 5,000 restricted stock units, each representing one share of Medpace common stock, and 10,000 employee stock options with a $410.54 exercise price expiring on April 24, 2033. The options that were exercised had vested in full on February 15, 2026, while the new RSUs and options vest in full on the fifth anniversary of the grant date, subject to his continued employment.

Positive

  • None.

Negative

  • None.
Insider EWALD STEPHEN P
Role General Counsel & Corp. Secy.
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) 3,500 $0.00 --
Grant/Award Employee Stock Option (Right to Buy) 10,000 $0.00 --
Grant/Award Restricted Stock Unit 5,000 $0.00 --
Exercise Common Stock 3,500 $138.87 $486K
Holdings After Transaction: Employee Stock Option (Right to Buy) — 16,349 shares (Direct, null); Restricted Stock Unit — 5,000 shares (Direct, null); Common Stock — 20,343 shares (Direct, null)
Footnotes (1)
  1. The option vested in full on February 15, 2026. The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock. The restricted stock units vest in full on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Options exercised 3,500 shares at $138.87 Employee stock options exercised into common stock
Shares held after exercise 20,343 shares Direct common stock ownership after reported transactions
RSUs granted 5,000 units Each RSU equals one Medpace common share
New options granted 10,000 options at $410.54 Employee stock options expiring April 24, 2033
Option vesting date (exercised) February 15, 2026 Previously granted options vested in full on this date
Vesting schedule (new awards) 5-year cliff vesting RSUs and options vest on fifth anniversary of grant
Restricted Stock Unit financial
"The filing reports a grant of 5,000 Restricted Stock Units."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
Employee Stock Option (Right to Buy) financial
"Two Employee Stock Option (Right to Buy) entries are disclosed."
exercise or conversion of derivative security financial
"Transaction code M is described as exercise or conversion of derivative security."
grant, award, or other acquisition financial
"Transaction code A is described as grant, award, or other acquisition."
contingent right to receive one share financial
"Each restricted stock unit represents a contingent right to receive one share."
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
EWALD STEPHEN P
(Last)(First)(Middle)
C/O MEDPACE HOLDINGS,INC.
5375 MEDPACE WAY
(Street)
CINCINNATI OHIO 45227
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Medpace Holdings, Inc. [ MEDP ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
General Counsel & Corp. Secy.
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/24/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/24/2026M3,500A$138.8720,343D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (Right to Buy)$138.8704/24/2026M3,500 (1)08/15/2027Common Stock3,500$016,349D
Employee Stock Option (Right to Buy)$410.5404/24/2026A10,000 (2)04/24/2033Common Stock10,000$010,000D
Restricted Stock Unit(3)04/24/2026A5,000 (4) (4)Common Stock5,000$05,000D
Explanation of Responses:
1. The option vested in full on February 15, 2026.
2. The option vests on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
3. Each restricted stock unit represents a contingent right to receive one share of MEDP common stock.
4. The restricted stock units vest in full on the fifth anniversary of the grant date, subject to the Reporting Person's continued employment with the Issuer or one of its subsidiaries.
Remarks:
/s/ Stephen P. Ewald04/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did Medpace (MEDP) report for Stephen P. Ewald?

Medpace reported that General Counsel Stephen P. Ewald exercised employee stock options to acquire 3,500 shares of common stock at $138.87 per share and received grants of 5,000 restricted stock units and 10,000 new stock options as equity compensation awards.

How many Medpace (MEDP) shares does Stephen P. Ewald hold after these Form 4 transactions?

Following the reported transactions, Stephen P. Ewald directly holds 20,343 shares of Medpace common stock. This figure reflects his ownership after exercising options for 3,500 shares, in addition to the separate derivative awards disclosed for restricted stock units and new stock options.

What equity awards did Stephen P. Ewald receive from Medpace (MEDP) on April 24, 2026?

On April 24, 2026, Stephen P. Ewald received 5,000 restricted stock units and 10,000 employee stock options. Each restricted stock unit represents one share of Medpace common stock, and the options have a $410.54 exercise price and expire on April 24, 2033.

What are the vesting terms for Stephen P. Ewald’s new Medpace (MEDP) equity awards?

The new restricted stock units and stock options granted to Stephen P. Ewald vest in full on the fifth anniversary of the grant date. Vesting is conditioned on his continued employment with Medpace Holdings, Inc. or one of its subsidiaries through that fifth-anniversary date.

At what prices did Stephen P. Ewald’s Medpace (MEDP) options transact in this Form 4?

Stephen P. Ewald exercised employee stock options for 3,500 shares of Medpace common stock at an exercise price of $138.87 per share. He was also granted new options on 10,000 shares with a higher exercise price of $410.54 per share, expiring in 2033.

Were any Medpace (MEDP) shares sold in Stephen P. Ewald’s reported Form 4 transactions?

The Form 4 reports only acquisitions: an option exercise for 3,500 shares of common stock and grants of 5,000 restricted stock units and 10,000 stock options. It does not show any sales, gifts, or tax-withholding dispositions in these transactions.